Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2019 Filed Aug 5, 2019 13:05 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 880 | $24.12 | $21,228.24 |
DisclosureSEC source: 0000784199-19-000143 · certent-form5.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| January 01, 2019 Filed Aug 5, 2019 13:06 UTC |
Holloway Jean FVP, General Counsel
|
GrantESPP · Derivative | 498 | $24.12 Strike: $24.12 | $12,013.25 |
DisclosureSEC source: 0000784199-19-000145 · certent-form5.xml · derivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498 Underlying: Common Stock · 498 shares Expires 2019-06-30 Read SEC document |
| January 01, 2019 Filed Aug 5, 2019 13:06 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 498 | $24.12 | $12,013.25 |
DisclosureSEC source: 0000784199-19-000145 · certent-form5.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| January 01, 2019 Filed Jan 29, 2020 21:49 UTC |
Maier Dennis BVice President, Operations
|
GrantESPP · Derivative | 108 | $24.12 Strike: $24.12 | $2,605.28 |
DisclosureSEC source: 0000784199-20-000008 · certent-form5.xml · derivative · entry 3 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108 Underlying: Common Stock · 108 shares Expires 2019-06-30 Read SEC document |
| January 01, 2019 Filed Jan 29, 2020 21:49 UTC |
Maier Dennis BVice President, Operations
|
Exercise / conversionCommon Stock | 108 | $24.12 | $2,605.28 |
DisclosureSEC source: 0000784199-20-000008 · certent-form5.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 31, 2018 Filed Feb 19, 2019 12:46 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionStock Option(Right to Buy) · Derivative | 307 | $23.67 Strike: $23.67 | $7,267.46 |
DisclosureSEC source: 0000784199-19-000004 · certent-form5.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 307 shares Expires 2018-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2018 Filed Feb 19, 2019 12:46 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 307 | $23.67 | $7,267.46 |
DisclosureSEC source: 0000784199-19-000004 · certent-form5.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. F2 · balance_after: In a Form 4 filed on July 10, 2018, Reporting Person over reported the total number of shares beneficially owned by a de minimus number of shares. As a result, such shares were reflected in the post-transaction amounts in column 5 of that Form 4. Beneficially owned shares are hereby updated in column 5 on this Form 5 to remove such previously-added shares. Read SEC document |
| December 31, 2018 Filed Feb 19, 2019 12:48 UTC |
Saurini Sherry MVP, Quality
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 113 | $23.67 Strike: $23.67 | $2,674.99 |
DisclosureSEC source: 0000784199-19-000008 · certent-form5.xml · derivative · entry 3 Saurini Sherry M · CIK 0001666007 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 113 shares Expires 2018-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2018 Filed Feb 19, 2019 12:48 UTC |
Saurini Sherry MVP, Quality
|
Exercise / conversionCommon Stock | 113 | $23.67 | $2,674.99 |
DisclosureSEC source: 0000784199-19-000008 · certent-form5.xml · nonDerivative · entry 1 Saurini Sherry M · CIK 0001666007 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. F2 · balance_after: In a Form 4 filed on July 10, 2018, Reporting Person over reported the total number of shares beneficially owned by a de minimus number of shares. As a result, such shares were reflected in the post-transaction amounts in column 5 of that Form 4. Beneficially owned shares are hereby updated in column 5 on this Form 5 to remove such previously-added shares. Read SEC document |
| December 31, 2018 Filed Feb 19, 2019 12:47 UTC |
McDermid James MSVP, CHRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 89 | $23.67 Strike: $23.67 | $2,106.85 |
DisclosureSEC source: 0000784199-19-000006 · certent-form5.xml · derivative · entry 3 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89 shares Expires 2018-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2018 Filed Feb 19, 2019 12:47 UTC |
McDermid James MSVP, CHRO
|
Exercise / conversionCommon Stock | 89 | $23.67 | $2,106.85 |
DisclosureSEC source: 0000784199-19-000006 · certent-form5.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. F2 · balance_after: In a Form 4 filed on July 10, 2018, Reporting Person over reported the total number of shares beneficially owned by a de minimus number of shares. As a result, such shares were reflected in the post-transaction amounts in column 5 of that Form 4. Beneficially owned shares are hereby updated in column 5 on this Form 5 to remove such previously-added shares. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 21:02 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 3,333 | $9.64 Strike: $9.64 | $32,130.12 |
DisclosureSEC source: 0000784199-18-000191 · certent-form4.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,333 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/10/2016. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 21:02 UTC |
Davis John ESenior VP, Global Sales
|
SaleCommon Stock | 3,333 | $33.86 | $112,843.05 |
DisclosureSEC source: 0000784199-18-000191 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,231 F2 · price: Reflects the avg weighted price of $33.8563 that the shares were sold. The prices ranged from $33.70 - $33.90. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 21:02 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 3,333 | $9.64 | $32,130.12 |
DisclosureSEC source: 0000784199-18-000191 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 20:51 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 2,201 | $34.00 | $74,834.00 |
DisclosureSEC source: 0000784199-18-000189 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,385 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 20:50 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 3,512 | $34.00 | $119,408.00 |
DisclosureSEC source: 0000784199-18-000187 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,231 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| September 05, 2018 Filed Sep 6, 2018 20:21 UTC |
RONALD C ELKINSDirector
|
SaleCommon Stock | 5,000 | $34.53 | $172,672.00 |
DisclosureSEC source: 0000784199-18-000185 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,843 F1 · price: Reflects the weighted avg price of $34.5344 the shares were sold. The range was from $34.50 to $34.60. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 22:59 UTC |
Capps Scott BVP, Clinical Research
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,332 | $5.67 Strike: $5.67 | $47,242.44 |
DisclosureSEC source: 0000784199-18-000183 · certent-form4.xml · derivative · entry 3 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,332 shares Expires 2019-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/18/2013 Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 22:59 UTC |
Capps Scott BVP, Clinical Research
|
SaleCommon Stock | 6,332 | $34.10 | $215,921.20 |
DisclosureSEC source: 0000784199-18-000183 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,087 F1 · price: Reflects weighted average price. Range was from $34.10 to $34.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 22:59 UTC |
Capps Scott BVP, Clinical Research
|
Exercise / conversionCommon Stock | 8,332 | $5.67 | $47,242.44 |
DisclosureSEC source: 0000784199-18-000183 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2018 Filed Aug 29, 2018 20:54 UTC |
Mackin James PPresident & CEO
|
OtherCommon Stock | 34,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000181 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,298 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 13:26 UTC |
Holloway Jean FVP, General Counsel
|
GiftCommon Stock | 3,149 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000179 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,586 F1 · shares: 3149 shares were gifted by the reporting person to a charity Read SEC document |
| August 15, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 9,851 | $10.24 Strike: $10.24 | $100,874.24 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · derivative · entry 9 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,265 Underlying: Common Stock · 9,851 shares Expires 2021-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/2/2015 Read SEC document |
| August 15, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 9,851 | $31.79 | $313,208.60 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 6 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,898 F3 · price: Reflects weighted average price. Range of prices were between $31.75 to $31.90. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionCommon Stock | 9,851 | $10.24 | $100,874.24 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 5 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 21:24 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 16,666 | $5.67 Strike: $5.67 | $94,496.22 |
DisclosureSEC source: 0000784199-18-000177 · certent-form4.xml · derivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires 2019-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/18/2013 Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 21:24 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
SaleCommon Stock | 16,666 | $31.92 | $531,993.72 |
DisclosureSEC source: 0000784199-18-000177 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,732 F2 · price: Reflects weighted average price. Range was $31.74 to $32.04. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 21:24 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 16,666 | $5.67 | $94,496.22 |
DisclosureSEC source: 0000784199-18-000177 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 14, 2018. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:49 UTC |
MORGAN HARVEYDirector
|
SaleCommon Stock | 2,369 | $32.66 | $77,372.96 |
DisclosureSEC source: 0000784199-18-000175 · certent-form4.xml · nonDerivative · entry 3 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned by spouse Disclosed balance after: 38,298 F2 · price: Reflects weighted average price. Range of prices were between $32.65 to $32.70. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:49 UTC |
MORGAN HARVEYDirector
|
SaleCommon Stock | 2,443 | $32.66 | $79,776.41 |
DisclosureSEC source: 0000784199-18-000175 · certent-form4.xml · nonDerivative · entry 2 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,939 F2 · price: Reflects weighted average price. Range of prices were between $32.65 to $32.70. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 37,077 | $10.24 Strike: $10.24 | $379,668.48 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · derivative · entry 8 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,116 Underlying: Common Stock · 37,077 shares Expires 2021-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/2/2015 Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 37,077 | $32.22 | $1,194,472.63 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,898 F2 · price: Reflects weighted average price. Range of prices were between $32.00 to $32.95. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionCommon Stock | 37,077 | $10.24 | $379,668.48 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:49 UTC |
MORGAN HARVEYDirector
|
SaleCommon Stock | 5,188 | $32.44 | $168,283.16 |
DisclosureSEC source: 0000784199-18-000175 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,382 F1 · price: Reflects weighted average price. Range of prices were between $32.25 to $32.80. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 103,072 | $10.24 Strike: $10.24 | $1,055,457.28 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · derivative · entry 7 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,193 Underlying: Common Stock · 103,072 shares Expires 2021-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/2/2015 Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 103,072 | $32.17 | $3,315,949.93 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,898 F1 · price: Reflects weighted average price. Range of prices were between $32.00 to $32.625. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:48 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionCommon Stock | 103,072 | $10.24 | $1,055,457.28 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:43 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 19,152 | $33.67 | $644,916.79 |
DisclosureSEC source: 0000784199-18-000169 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,898 F2 · price: Reflects weighted average price. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:43 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 23,523 | $33.03 | $777,051.73 |
DisclosureSEC source: 0000784199-18-000169 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,050 F1 · price: Reflects weighted average price. Range of prices were between $32.80 to $33.60. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:37 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
SaleCommon Stock | 10,247 | $32.98 | $337,923.52 |
DisclosureSEC source: 0000784199-18-000165 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,732 F1 · price: Reflects weighted average price. Range was $33.20 to $33.40. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:31 UTC |
RONALD C ELKINSDirector
|
SaleCommon Stock | 1,154 | $33.27 | $38,393.23 |
DisclosureSEC source: 0000784199-18-000159 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,843 F1 · price: Reflects the average price of $33.2697 the shares were sold. Range of prices were between $33.20 - $33.40. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:34 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $10.28 Strike: $10.28 | $15,420.00 |
DisclosureSEC source: 0000784199-18-000161 · certent-form4.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 4/1/2016 Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:34 UTC |
Holloway Jean FVP, General Counsel
|
SaleCommon Stock | 1,500 | $33.50 | $50,250.00 |
DisclosureSEC source: 0000784199-18-000161 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,735 F2 · price: Reflects the price of $33.50 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:34 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 1,500 | $10.28 | $15,420.00 |
DisclosureSEC source: 0000784199-18-000161 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 14, 2018. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:35 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 3,000 | $32.85 | $98,550.00 |
DisclosureSEC source: 0000784199-18-000163 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,453 F1 · price: Reflects the price the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC |
Mackin James PPresident & CEO
|
OtherStock Option (Right to Buy) · Derivative | 28,412 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 5 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,225 Underlying: Common Stock · 28,412 shares Expires 2024-02-21 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC |
Mackin James PPresident & CEO
|
OtherStock Option (Right to Buy) · Derivative | 54,123 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,549 Underlying: Common Stock · 54,123 shares Expires 2023-02-19 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC |
Mackin James PPresident & CEO
|
OtherStock Option (Right to Buy) · Derivative | 42,552 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,553 Underlying: Common Stock · 42,552 shares Expires 2022-02-19 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC |
Mackin James PPresident & CEO
|
OtherStock Option (Right to Buy) · Derivative | 204,266 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,265 Underlying: Common Stock · 204,266 shares Expires 2021-09-02 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC |
Mackin James PPresident & CEO
|
OtherCommon Stock | 30,522 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,573 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.